EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characterization of Incident Interstitial Lung Disease in Late Systemic Sclerosis

Sabrina Hoa, Claudie Berger, Nouha Lahmek, Maggie Larché, Mohammed Osman iD, May Choi iD, Janet Pope iD, Carter Thorne, Canadian Scleroderma Research Group, Marie Hudson

Arthritis & Rheumatology · 2025-04 · 77 (4) · 450-457

DOI: 10.1002/art.43051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 07.01.2025. Verfasst von Sabrina Hoa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Scleroderma, Systemic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Université de Montréal Scleroderma Chair, Sclérodermie Quebec, Fonds de Recherche du Québec en Santé.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Interstitial lung disease (ILD) is a common and potentially lethal complication of systemic sclerosis (SSc). Screening by high‐resolution computed tomography (HRCT) is recommended in all patients with risk factors, including early disease. Little is known on late presentations of ILD. This study aimed to characterize the incidence, risk factors, and outcomes of late‐onset SSc‐ILD.

Methods

Study participants enrolled in the Canadian Scleroderma Research Group cohort from 2004 to 2020 without prevalent ILD were included. Incidence and risk factors for ILD (on HRCT) were compared according to disease duration above (late) and below (earlier) seven years from the first non‐Raynaud manifestation. Risk of ILD progression was compared using Kaplan‐Meier and multivariable Cox models.

Results

Overall, 199 (21%) of 969 patients developed incident ILD over a median of 2.4 (interquartile range 1.2–4.3) years. The incidence rate in late SSc (3.7/100 person‐years) was lower than in earlier SSc (relative risk 0.68, 95% confidence interval [CI] 0.51–0.92). Risk factors for incident ILD included male sex, diffuse subtype, myositis, antitopoisomerase I autoantibodies, and higher C‐reactive protein levels. Patients with late‐onset ILD were also less frequently White and more frequently had arthritis and anti‐RNA‐polymerase III autoantibodies. Lung disease severity was similar between late‐ and earlier‐onset SSc‐ILD (forced vital capacity 88% and 87%, diffusion capacity of the lungs for carbon monoxide 64% and 62%, respectively). Progression rates were also similar between late‐ and earlier‐onset SSc‐ILD (log rank P = 0.8, hazard ratio 1.11, 95% CI 0.58–2.10).

Conclusion

ILD can present in late SSc. Risk factors and progression rates overlapped with earlier‐onset SSc‐ILD. Surveillance for ILD should continue in longstanding SSc. Frequency and modality of monitoring remain to be defined.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialScleroderma, SystemicHumansMaleFemaleIncidenceMiddle AgedRisk FactorsAgedCanadaDisease ProgressionTomography, X-Ray ComputedProportional Hazards ModelsAdult

Autor:innen und Institutionen

  • Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
  • Research Institute of the McGill University Health Center, Montréal, Québec, Canada.
  • McMaster University, Hamilton, Ontario, Canada, and University of Calgary, Calgary, Alberta, Canada.
  • University of Alberta, Edmonton, Alberta, Canada.
  • University of Calgary, Calgary, Alberta, Canada.
  • University of Western Ontario, London, Canada.

ORCID-Profile: Mohammed Osman, May Choi, Janet Pope

Förderung

  • Université de Montréal Scleroderma Chair
  • Sclérodermie Quebec
  • Fonds de Recherche du Québec en Santé

Zitieren

APA

Hoa, S., Berger, C., Lahmek, N., Larché, M., Osman, M., Choi, M., Pope, J., Thorne, C., Canadian Scleroderma Research Group, & Hudson, M. (2025). Characterization of Incident Interstitial Lung Disease in Late Systemic Sclerosis. Arthritis & Rheumatology, 77(4), 450-457. https://doi.org/10.1002/art.43051

Vancouver

Hoa S, Berger C, Lahmek N, Larché M, Osman M, Choi M, et al. Characterization of Incident Interstitial Lung Disease in Late Systemic Sclerosis. Arthritis & Rheumatology. 2025;77(4):450-457. doi:10.1002/art.43051

BibTeX
@article{Hoa2025,
  author = {Hoa, Sabrina and Berger, Claudie and Lahmek, Nouha and Larché, Maggie and Osman, Mohammed and Choi, May and Pope, Janet and Thorne, Carter and Canadian Scleroderma Research Group, Canadian Scleroderma Research Group and Hudson, Marie},
  title = {Characterization of Incident Interstitial Lung Disease in Late Systemic Sclerosis},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  volume = {77},
  number = {4},
  pages = {450--457},
  doi = {10.1002/art.43051}
}
Kostenlos starten →